Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Sonny Blue who wrote (715)	5/5/1998 4:47:00 PM
From: Tom Caruthers	Read Replies (1) \| Respond to of 2135

Hmmm...I wonder what a short squeeze looks like. So, everyone and their mother is shorting this stock, yet it only goes down $8 and change. People are reporting that there are no more shares to short at discount brokerages...not that surprising. So what happens when there are no more shares to short? What if....for instance....given the great excitement generated in the past couple of days....that a big pharma deal is in the works? Nothing like the whole world focusing on one stock to attract the upper management of most big pharma companies. Bristol Myers Squibb came out yesterday and tried to quell the enthusiasm...as rightly they should have (if only to reduce patients' expectations)....but is there some ulterior motive here? Too much excitement over ENMD's products when no agreement has yet been signed? Do you think that BMY would have been so adamant in their statement had they already inked a deal with ENMD? The fact is: ENMD is in an enviable position right now. They have huge Wall St awareness, two potential blockbuster products (angio and Endostatin), thalidomide, IHP, etc...a decent cash position...What a way to bargain with big pharma. A positive dog result, an announcement of expedited trials, a pharma buyout, equity stake, or alliance...in the future?? I am just glad that I can participate in what I feel will be one of the great success stories for mankind in this lifetime. Good luck all, and don't worry about the stock price. Pray that endostatin and angiostatin will work in man....not because it will make you money but perhaps it may help someone you know in the future. Tom

To: Sonny Blue who wrote (715)	5/5/1998 10:17:00 PM
From: John Bloxom	Respond to of 2135

Can't say just yet on the re-entry price. My sense is that it will go back into the twenties, although I think it will be on one of those days during which the Dow loses 500 and the Naz gives up 50. Until then I see it in the thirties, perhaps. I'd like to think that the market is more disciplined than that, but experience has taught me otherwise. The market, for instance, has been of the view within the past few months that the stock is worth both $6.50 per share and $86.50 per share. From that I conclude that the market simply hasn't a clue. Regards, John